Pain Assessment During Less Invasive Surfactant Administration Using Skin Conductance: A Prospective Cohort Study

Background: Less Invasive Surfactant Administration (LISA) is an established treatment for surfactant deficiency. However, analgosedation for LISA remains controversial. The aim of this study was to assess pain using skin conductance (SC) measurements during LISA. Methods: This prospective cohort study included preterm infants born at ≥27 weeks. Pain was assessed using SC and blinded Neonatal Pain, Agitation and Sedation Scale (N-PASS) scoring. Primary outcome was change to baseline in SC peaks per second (PPS) at pre-specified events. Secondary outcomes included N-PASS scores and changes in cardiorespiratory parameters. Results: Twenty infants were included in the analysis. SC-PPS were increased during nasopharyngeal tube (NPT) insertion, but no more significant after adjusting for chronological age. SC-PPS were not increased at any other pre-specified event during LISA. N-PASS scores indicated elevated pain levels during NPT insertion (Δ = 3.28, 95%-CI: 1.37 to 5.20) and laryngoscopy (Δ = 3.60, 95%-CI 1.77 to 5.43). SC and N-PASS scores showed a weak correlation (Kendall's τ = 0.17; 95%-CI: 0.02 to 0.31). Conclusion: LISA was not associated with elevated SC-PPS, despite increased N-PASS scores during specific procedural steps. This may reflect technical limitations of SC monitoring immediately after birth in preterm infants. Clinical trial registration: ClinicalTrials.gov (NCT06150586) IMPACT: Skin conductance (SC) measurement has been proposed as an objective method for pain assessment in preterm infants. In our study, SC did not indicate a pain response in infants undergoing Less Invasive Surfactant Administration (LISA). Our findings suggest that SC alone may not be a reliable indicator of procedural pain in preterm infants shortly after birth. There remains a critical need for objective methods to assess pain in preterm infants. Further research is required to validate SC for neonatal pain assessment.

Authors

Publication Details

Journal
Universität Zürich, ZORA
Published
2025-12-22
DOI
https://doi.org/10.5167/uzh-282552
Primary Topic
Pediatric Pain Management Techniques
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pain Assessment During Less Invasive Surfactant Administration Using Skin Conductance: A Prospective Cohort Study

Vinzenz Boos, Ulrike Held, Coralie Dirler, Stephan Benke-Bruderer et al.
Universität Zürich, ZORA
Pediatric Pain Management Techniques
article

Pain Assessment During Less Invasive Surfactant Administration Using Skin Conductance: A Prospective Cohort Study

Vinzenz Boos, Ulrike Held, Coralie Dirler, Stephan Benke-Bruderer, Dirk Bassler, Christoph Rüegger, Tobias Muehlbacher
article en

Abstract

Background: Less Invasive Surfactant Administration (LISA) is an established treatment for surfactant deficiency. However, analgosedation for LISA remains controversial. The aim of this study was to assess pain using skin conductance (SC) measurements during LISA. Methods: This prospective cohort study included preterm infants born at ≥27 weeks. Pain was assessed using SC and blinded Neonatal Pain, Agitation and Sedation Scale (N-PASS) scoring. Primary outcome was change to baseline in SC peaks per second (PPS) at pre-specified events. Secondary outcomes included N-PASS scores and changes in cardiorespiratory parameters. Results: Twenty infants were included in the analysis. SC-PPS were increased during nasopharyngeal tube (NPT) insertion, but no more significant after adjusting for chronological age. SC-PPS were not increased at any other pre-specified event during LISA. N-PASS scores indicated elevated pain levels during NPT insertion (Δ = 3.28, 95%-CI: 1.37 to 5.20) and laryngoscopy (Δ = 3.60, 95%-CI 1.77 to 5.43). SC and N-PASS scores showed a weak correlation (Kendall's τ = 0.17; 95%-CI: 0.02 to 0.31). Conclusion: LISA was not associated with elevated SC-PPS, despite increased N-PASS scores during specific procedural steps. This may reflect technical limitations of SC monitoring immediately after birth in preterm infants. Clinical trial registration: ClinicalTrials.gov (NCT06150586) IMPACT: Skin conductance (SC) measurement has been proposed as an objective method for pain assessment in preterm infants. In our study, SC did not indicate a pain response in infants undergoing Less Invasive Surfactant Administration (LISA). Our findings suggest that SC alone may not be a reliable indicator of procedural pain in preterm infants shortly after birth. There remains a critical need for objective methods to assess pain in preterm infants. Further research is required to validate SC for neonatal pain assessment.

Universität Zürich, ZORA
Good health and well-being
Openalex Percentile: Top 16%
Pediatric Pain Management Techniques
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Pain Assessment During Less Invasive Surfactant Administration Using Skin Conductance: A Prospective Cohort Study — Vinzenz Boos, Ulrike Held, et al. · Universität Zürich, ZORA (2025) | TGRS Research Map | TGRS